Top

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Published in:

Open Access 01-12-2023 | Guillain-Barré Syndrome | Letter to the Editor

Author response to "Absence of proximal muscle weakness, dysarthria, and facial diplegia suggest Guillain–Barre syndrome rather than CIDP"

Authors: Dimitrios Tsiptsios, Aggeliki Fotiadou, Stella Karatzetzou, Sofia Kitmeridou, Ioannis Iliopoulos

Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery | Issue 1/2023

Abstract

In many instances, the differential diagnosis between Guillain–Barre syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP) may be challenging. The aim of this letter to the editor is to elucidate comments and concerns raised, regarding our latest published article dealing with two patients that developed acute-onset CIDP after SARS-CoV-2 infection and Ad26.COV2.S vaccination, respectively.

Finsterer J. Absence of proximal muscle weakness, dysarthria, and facial diplegia suggests Guillain-Barre syndrome rather than CIDP. Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):161. https://doi.org/10.1186/s41983-022-00598-z.CrossRefPubMedPubMedCentral

Fotiadou A, Tsiptsios D, Karatzetzou S, Kitmeridou S, Iliopoulos J. Acute onset chronic inflammatory demyelinating polyneuropathy complicating SARS-CoV-2 infection and Ad26.COV2.S vaccination: report of two cases. Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):116. https://doi.org/10.1186/s41983-022-00515-4.CrossRefPubMedPubMedCentral

Ruts L, Drenthen J, Jacobs BC, van Doorn PA, Dutch GBS Study Group. Distinguishing acute-onset CIDP from fluctuating Guillain–Barre syndrome: a prospective study. Neurology. 2010;74(21):1680–6. https://doi.org/10.1212/WNL.0b013e3181e07d14.CrossRefPubMed

Bagella CF, Corda DG, Zara P, Elia AE, Ruiu E, Sechi E, Solla P. Chronic inflammatory demyelinating polyneuropathy after ChAdOx1 nCoV-19 vaccination. Vaccines (Basel). 2021;9(12):1502. https://doi.org/10.3390/vaccines9121502.CrossRefPubMed

de Souza A, Oo WM, Giri P. Inflammatory demyelinating polyneuropathy after the 226 ChAdOx1 nCoV-19 vaccine may follow a chronic course. J Neurol Sci. 2022;436: 120231.CrossRefPubMedPubMedCentral

Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, Attarian S, Blomkwist-Markens PH, Cornblath DR, Eftimov F, Goedee HS, Harbo T, Kuwabara S, Lewis RA, Lunn MP, Nobile-Orazio E, Querol L, Rajabally YA, Sommer C, Topaloglu HA. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force-Second revision. J Peripher Nerv Syst. 2021;26(3):242–68. https://doi.org/10.1111/jns.12455.CrossRefPubMed

van Doorn PA. Diagnosis, treatment and prognosis of Guillain–Barré syndrome 228 (GBS). La Presse Médicale. 2013;42(6):e193-201.CrossRefPubMed

Zivković SA, Peltier AC, Iacob T, Lacomis D. Chronic inflammatory demyelinating polyneuropathy and ventilatory failure: report of seven new cases and review of the literature. Acta Neurol Scand. 2011;124(1):59–63. https://doi.org/10.1111/j.1600-0404.2010.01431.x.CrossRefPubMed

Raahimi MM, Kane A, Moore CE, Alareed AW. Late onset of Guillain–Barré syndrome following SARS-CoV-2 infection: part of “long COVID-19 syndrome”? BMJ Case Rep. 2021;14(1): e240178. https://doi.org/10.1136/bcr-2020-240178.CrossRefPubMedPubMedCentral

10.

Taguchi M, Bonner K, Memon AB. Late-onset Guillain–Barré syndrome and right facial nerve palsy after COVID-19 infection. Case Rep Neurol. 2022;14(1):12–8. https://doi.org/10.1159/000521245.CrossRefPubMedPubMedCentral

11.

Fletman EW, Stumpf N, Kalimullah J, Levinson N, Deboo A. Guillain–Barré syndrome associated with COVID-19: an atypical, late-onset presentation. Neurol Sci. 2021;42(11):4393–5. https://doi.org/10.1007/s10072-021-05336-6.CrossRefPubMedPubMedCentral

12.

Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, van Doorn PA, Dourado ME, Hughes RAC, Islam B, Kusunoki S, Pardo CA, Reisin R, Sejvar JJ, Shahrizaila N, Soares C, Umapathi T, Wang Y, Yiu EM, Willison HJ, Jacobs BC. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol. 2019;15(11):671–83. https://doi.org/10.1038/s41582-019-0250-9.CrossRefPubMedPubMedCentral

Title: Author response to "Absence of proximal muscle weakness, dysarthria, and facial diplegia suggest Guillain–Barre syndrome rather than CIDP"
Authors: Dimitrios Tsiptsios
Aggeliki Fotiadou
Stella Karatzetzou
Sofia Kitmeridou
Ioannis Iliopoulos
Publication date: 01-12-2023
Publisher: Springer Berlin Heidelberg
Keywords: Guillain-Barré Syndrome
SARS-CoV-2
Vaccination
Polyneuropathy
Dysarthria
COVID-19
COVID-19 Vaccination
Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery / Issue 1/2023
Electronic ISSN: 1687-8329
DOI: https://doi.org/10.1186/s41983-023-00689-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Author response to "Absence of proximal muscle weakness, dysarthria, and facial diplegia suggest Guillain–Barre syndrome rather than CIDP"

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2023

Second-generation antipsychotic medications and metabolic disturbance in children and adolescents

Factors influencing hemorrhagic transformation in ischemic stroke patients with atrial fibrillation: a hospital based-study

Effects of primary motor cortex noninvasive brain stimulation on post-stroke aphasia: a narrative review

Re-appraisal of callosotomy: rates and predictors of short-term seizure outcome in pediatric epileptic encephalopathy

Synthetic cannabinoids impact on cognitive functions

Regular Islamic prayers have different corpus callosum: a shape analysis study